Skip to main content

Novartis and Roche are among the most innovative companies

| News

Novartis and Roche are among the most innovative companies


Novartis and Roche feature among the hundred most innovative companies worldwide. This is from the Derwent Top 100 Global Innovators 2020 report. Roche is the only pharmaceutical company worldwide that has appeared in the list nine times.

Basel with Roche and Messe towers (img: Adriano Biondo)

The consulting company Clarivate Analytics based in London and Philadelphia has analyzed a total of 14,000 companies worldwide for its report Derwent Top 100 Global Innovators 2020. It lists two companies from Basel as some of the most innovative firms in the world. The pharmaceutical company Novartis has featured in this list every year since 2015 and is now one of the hundred most innovative companies in the world for the sixth time running. Its local competitor Roche has had a continuous presence in the list since 2012, making it the only pharmaceutical company in the world to be one of the globally most innovative companies for the ninth time. The third Swiss company in the list is ABB, a technology firm from Zurich.

These three entries in the list make Switzerland one of the most innovative countries in the world. China and South Korea are also represented by three listings, Taiwan and Germany by four companies, and France by five. The USA is now at the top of the list, with 39 innovative companies, which is six more than the previous year. Japan is still doing well, but with seven fewer companies than last year, it takes second place with 32 firms.

The analysts from Clarivate Analytics not only use the number of patents granted to the companies but also their influence on other innovators and their presence in the various major global markets to support their assessment. They also point out that the importance of large companies is dwindling in the world of innovation. The thousand most innovative companies in the world in 2019 only possessed 18 percent of all patents. Six years before, this was 27 percent. At the same time, they say that it is becoming more and more difficult for up-and-coming companies to gain access into the exclusive circle of the most innovative companies. stk

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

The power of a persuasive pitch deck

Are you an entrepreneur striving to secure investment for your biotech startup? Start with an effective pitch deck to catch...
Read More

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Do you have a question? We'd like to hear from you.